Kaposi's Sarcoma: A Review and Recent Developments
1981; Wiley; Volume: 31; Issue: 1 Linguagem: Inglês
10.3322/canjclin.31.1.2
ISSN1542-4863
Autores Tópico(s)Histiocytic Disorders and Treatments
ResumoCA: A Cancer Journal for CliniciansVolume 31, Issue 1 p. 2-12 ArticleFree Access Kaposi's sarcoma: A review and recent developments Bijan Safai M.D., Bijan Safai M.D. Associate Attending Physician, Chief, Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New YorkSearch for more papers by this authorRobert A. Good Ph.D., M.D., Robert A. Good Ph.D., M.D. Vice President, Memorial Sloan-Kettering Cancer Center, New York, New YorkSearch for more papers by this author Bijan Safai M.D., Bijan Safai M.D. Associate Attending Physician, Chief, Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New YorkSearch for more papers by this authorRobert A. Good Ph.D., M.D., Robert A. Good Ph.D., M.D. Vice President, Memorial Sloan-Kettering Cancer Center, New York, New YorkSearch for more papers by this author First published: January/February 1981 https://doi.org/10.3322/canjclin.31.1.2Citations: 31AboutReferencesRelatedInformationPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessClose modalShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Kaposi M: Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph 4: 265– 273, 1872. 2 Davis J: Kaposi's sarcoma. Present concept of clinical course and treatment. NY State J Med 68: 2067– 2073, 1968. 3 Dutz W, Stout AP: Kaposi's sarcoma in infants and children. Cancer 13: 684– 694, 1960. 4 Cox FH, Helwig EB: Kaposi's sarcoma. Cancer 12: 289– 298, 1959. 5 Oettle AG: Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Un Int Cancer 18: 330– 363, 1962. 6 Rothman S: Some clinical aspects of Kaposi's sarcoma in the European and North American populations. Acta Un Int Cancer 18: 364– 371, 1962. 7 Lothe F: Kaposi's sarcoma in Ugandan Africans. Acta Pathol Microbiol Scand 161: 1– 71, 1963. 8 Reynolds WA, Winkelmann RK, Soule EH: Kaposi's sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine 44: 419– 443, 1965. 9 Slavin G, Cameron HM, Singh H: Kaposi's sarcoma in mainland Tanzania: a report of 117 cases. Br J Cancer 23: 349– 357, 1969. 10 Taylor JF, Templeton AC, Vogel CL, et al: Kaposi's sarcoma in Uganda: a clinicopathological study. Int J Cancer 8: 122– 135, 1971. 11 Palmer PES: Haemangiosarcoma of Kaposi. Acta Radiol 12: 640, 1972. 12 Rogoff MG: Kaposi's sarcoma. Age, sex, and tribal incidence in Kenya, in P Clifford, CA Linsell, GL Timms (eds): Cancer in Africa. Nairobi, East Afr Med J, 1968, pp 445– 448. 13 Taylor JF, Smith PG, Bull D, et al: Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br J Cancer 26: 483– 497, 1972. 14 O'Brien PH, Brasfield RD: Kaposi's sarcoma. Cancer 19: 1497– 1502, 1966. 15 Templeton AC, Hutt MSR: Distribution of tumors in Uganda. Recent Results Cancer Res 41: 1– 22, 1973. 16 Oettle AG: Geographical and racial differences in frequency of Kaposi's sarcoma as evidence of environmental or genetic causes, in LV Ackerman, JF Murray (eds): Symposium on Kaposi's Sarcoma. New York, Hafner Publishing Co, 1963, pp 17– 50. 17 Rothman S: Remarks on sex, age, and racial distribution of Kaposi's sarcoma and on possible pathogenetic factors. Acta Un Int Cancer 18: 326– 329, 1962. 18 Mikkelsen F, Nielsen N, Hansen JP: Kaposi's sarcoma in polar Eskimos. Acta Derm Venereol 57: 539– 541, 1977. 19 Slavin G, Cameron HM, Forbes C, et al: Kaposi's sarcoma in East African children: a report of 51 cases. J Pathol 100: 187– 199, 1970. 20 Epstein E: Kaposi's sarcoma and parapsoriasis en plaque in brothers. JAMA 219: 1477– 1478, 1972. 21 Brownstein MH, Shapiro L, Skolnik P: Kaposi's sarcoma in community practice. Arch Dermatol 107: 137– 138, 1973. 22 Keen P: The clinical features of Kaposi's sarcoma in the South African Bantu. Acta Un Int Cancer 18: 380– 387, 1962. 23 Rothman S: Medical research in Africa. Geographic pathology, Kaposi's sarcoma, and cutaneous physiology of pachyderms. Arch Dermatol 85: 311– 324, 1962. 24 Repler WJ: The ORIGIN of Kaposi's haemangiosarcoma: a histochemical study. J Pathol 78: 553– 557, 1959. 25 Becker BJ: The histogenesis of Kaposi's sarcoma. Acta Un Int Cancer 18: 477– 486, 1962. 26 Hashimoto K, Lever WF: Kaposi's sarcoma. Histochemical and electron microscopic studies. J Invest Dermatol 43: 539– 549, 1964. 27 Mustakallio KK, Levonen E, Raekallio J: Histochemistry of Kaposi's sarcoma. I. Hydrolases and phosphorylase. Exp Mol Pathol 2: 303– 316, 1963. 28 Loring WE, Wolman SR: Idiopathic multiple hemorrhagic sarcoma of lung (Kaposi's sarcoma). NY State J Med 65: 668– 676, 1965. 29 Dörffel J: Histogenesis of multiple idiopathic hemorrhagic sarcoma of Kaposi. Arch Dermatol Syph 26: 608– 634, 1932. 30 Dayan AD, Lewis PD: ORIGIN of Kaposi's sarcoma from the reticulo-endothelial system. Nature 213: 889– 890, 1967. 31 Giraldo G, Beth E, Haguenau F: Herpestype virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst 49: 1509– 1526, 1972. 32 Giraldo G, Beth E, Kourilsky FM, et al: Antibody patterns to herpesviruses in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus. Int J Cancer 15: 839– 848, 1975. 33 Giraldo G, Beth E, Henle W: Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of American Kaposi's sarcoma with cytomegalovirus. Int J Cancer 22: 126– 131, 1978. 34 Old LJ, Boyse EA, Oettgen HF, et al: Precipitating antibody in human serum to an anTIGen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci 56: 1699– 1704, 1966. 35 Henle G, Henle W, Clifford P, et al: Antibodies to Epstein-Ban virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43: 1147– 1157, 1969. 36 Zur Hausen H, Schulte-Holthausen H, Klein G, et al: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056– 1058, 1970. 37 Lindahl T, Klein G, Reedman BM, et al: Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear anTIGen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 13: 764– 772, 1974. 38 Henle G, Henle W, Diehl V: Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci 59: 94– 101, 1968. 39 Klemola E, Von Essen R, Henle G, et al: Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis 121: 608– 614, 1970. 40 Epstein MA, Achong BG: Pathogenesis of infectious mononucleosis. Lancet 2: 1270– 1273, 1977. 41 Albrecht T, Rapp F: Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology 55: 53– 61, 1973. 42 Pagano JS: Diseases and mechanisms of persistent DNA virus infection: latency and cellular transformation. J Infect Dis 132: 209– 223, 1975. 43 Rinaldo CR Jr, Black PH, Hirsch MS: Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis 136: 667– 678, 1977. 44 de-Thé G: Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus? Lancet 1: 335– 338, 1977. 45 Medearis DN Jr: Mouse cytomegalovirus infection. II. Observations during prolonged infections. Am J Hyg 80: 103– 112, 1964. 46 Olding LB, Kingsbury DT, Oldstone MB: Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes, and autoimmunity during latent murine infection. J Gen Virol 33: 267– 280, 1976. 47 Huang AS, Baltimore D: Defective interfering animal viruses, in H Fraenkel-Conrat, RR Wagner (eds): Comprehensive Virology. New York Plenum Press, 1977, vol 10, pp 73– 116. 48 Duff R, Rapp F: Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol 8: 469– 477, 1971. 49 Duff R, Rapp F: Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J Virol 12: 209– 217, 1973. 50 Geder L, Lausch R, O'Neill F, et al: Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science 192: 1134– 1137, 1976. 51 Master SP, Taylor JF, Kyalwazi SK, et al: Immunological studies in Kaposi's sarcoma in Uganda. Br Med J 1: 600– 602, 1970. 52 Taylor JF, Junge U, Wolfe L, et al: Lymphocyte transformation in patients with Kaposi's sarcoma. Int J Cancer 8: 468– 474, 1971. 53 Dobozy A, Husz S, Hunyadi J, et al: Immune deficiencies and Kaposi's sarcoma. Lancet 2: 625, 1973. 54 Taylor JF: Lymphocyte transformation in Kaposi's sarcoma. Lancet 1: 883– 884, 1973. 55 Taylor JF, Ziegler JL: Delayed cutaneous hypersensitivity reactions in patients with Kaposi's sarcoma. Br J Cancer 30: 312– 318, 1974. 56 Klein MB, Pereira FA, Kantor I: Kaposi's sarcoma complicating systemic lupus erythematosus treated with immunosuppression. Arch Dermatol 110: 602– 604, 1974. 57 Myers BD, Kessler E, Levi J, et al: Kaposi's sarcoma in kidney transplant recipients. Arch Intern Med 133: 307– 311, 1974. 58 Kapadia SB, Krause JR: Kaposi's sarcoma after long-term alkylating agent therapy for multiple myeloma. South Med J 70: 1011– 1013, 1977. 59 Mazzaferri EL, Penn GM: Kaposi's sarcoma associated with multiple myeloma. Report of a patient and review of the literature. Arch Intern Med 122: 521– 525, 1968. 60 Dantzig PI: Kaposi's sarcoma and polymyositis. Arch Dermatol 110: 605– 607, 1974. 61 Law IP: Kaposi's sarcoma and plasma cell dyscrasia. JAMA 229: 1329– 1331, 1974. 62 Ettinger DS, Humphrey RL, Skinner MD: Kaposi's sarcoma associated with multiple myeloma. Johns Hopkins Med J 137: 88– 90, 1975. 63 Mandel EM, Lask D, Gafter U, et al: Multiple myeloma associated with Kaposi's sarcoma. Acta Haematol 58: 120– 128, 1977. 64 Schreiber ZA, Haim S, Gellei B, et al: Autoimmune hemolytic anemia in the course of Kaposi's sarcoma—report of a case. Cancer 32: 922– 925, 1973. 65 Hardy MA, Goldfarb P, Levine S, et al: De novo Kaposi's sarcoma in renal transplantation: case report and brief review. Cancer 38: 144– 148, 1976. 66 Wang SC, Geller SA: Hypogammaglobulinemia associated with Kaposi's sarcoma. Mt Sinai J Med 44: 510– 514, 1977. 67 Harwood AR, Osoba D, Hofstader SL, et al: Kaposi's sarcoma in recipients of renal transplants. Am J Med 67: 759– 765, 1979. 68 Page AR, Hansen AE, Good RA: Occurrence of leukemia and lymphoma in patients with agammaglobulinemia. Blood 21: 197– 206, 1963. 69 Gatti RA, Good RA: Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28: 89– 98, 1971. 70 Moertel CG: Multiple primary malignant neoplasms; their incidence and significance. Recent Results Cancer Res 7: 34– 47, 1966. 71 Safai B, Miké V, Giraldo G, et al: Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer 45: 1472– 1479, 1980. 72 Moertel CG, Hagedorn AB: Leukemia or lymphoma and coexistent primary malignant lesions: a review of the literature and study of 120 cases. Blood 12: 788– 803, 1957. 73 Uys CJ, Bennet MB: Kaposi's sarcoma: a neoplasm of reticular ORIGIN. South Afr J Lab Clin Med 5: 39– 48, 1959. 74 Lothe F, Murray JF: Kaposi's sarcoma. Autopsy findings in the African, in Symposium on Kaposi's Sarcoma. Acta Un Int Cancer 18: 429– 452, 1962. 75 Wilson PR, Nishiyama RH: Lymph nodal Kaposi's sarcoma and chronic lymphocytic leukemia associated with a hepatic nodule simulating Hodgkin's disease. Cancer 27: 1419– 1425, 1971. Citing Literature Volume31, Issue1January/February 1981Pages 2-12 ReferencesRelatedInformation RecommendedClassic Kaposi sarcomaJose Iscovich M.D., Paolo Boffetta M.D., Silvia Franceschi M.D., Esther Azizi M.D., Ronit Sarid Ph.D., CancerClassic Kaposi sarcomaEmma Guttman-Yassky M.D., M.Sc., Jonathan Dubnov M.D., M.P.H., Zippi Kra-Oz Ph.D., Rachel Friedman-Birnbaum M.D., Michael Silbermann D.M.D., Ph.D., Micha Barchana M.D., M.P.H., Reuven Bergman M.D., Ronit Sarid Ph.D., CancerHuman immunodeficiency virus negative Kaposi sarcoma and lymphoproliferative disordersSilvia Fossati M.D., Vinicio Boneschi M.D., Silvia Ferrucci M.D., Lucia Brambilla M.D., CancerKaposi sarcoma of the musculoskeletal systemGabriel Caponetti MD, Bruce J. Dezube MD, Carlos S. Restrepo MD, Liron Pantanowitz MD, CancerThe appearance of kaposi sarcoma during corticosteroid therapyAkiva Trattner M.D., Emmilia Hodak M.D., Michael David M.D., Miriam Sandbank M.D., Cancer
Referência(s)